immunology 1, 2, 3
DESCRIPTION
Understanding Immunology for internistsTRANSCRIPT
![Page 1: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/1.jpg)
04/11/23 21:51
![Page 2: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/2.jpg)
04/11/23 21:51
Understanding Immunology
Dr. Ahmed Elshebiny , MDDr. Ahmed Elshebiny , MDLecturer of Internal MedicineLecturer of Internal Medicine
Faculty of Medicine, Menoufyia UniversityFaculty of Medicine, Menoufyia University
Former Clinical Research FellowFormer Clinical Research Fellow,,Joslin Diabetes Center, Harvard UniversityJoslin Diabetes Center, Harvard University
![Page 3: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/3.jpg)
04/11/23 21:51
Immunology Course Basics:
Immune system and disease Diseases:
Immunopatholy Applications:
Therapeutic applications
![Page 4: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/4.jpg)
04/11/23 21:51
Immune system and disease Immunity Immune system Innate Immunity Adaptive Immunity Immune Recognition
Cells of the Immune system Complement Immunoglobulins Cytokines
Human disease & Immunity Immunopathology Diagnostics Therapeutic applications
Structure andFunction of The
System
Cells and Molecules of
Immunity
Introduction toClinical
Immunology
![Page 5: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/5.jpg)
04/11/23 21:51
Immunity
![Page 6: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/6.jpg)
04/11/23 21:51
Immunity is characterized by:1. Specificity – activated by and responds to a
specific antigen
2. Versatility – is ready to confront any antigen at any time
3. Memory – “remembers” any antigen it has encountered
4. Tolerance – responds to foreign substances but ignores normal tissues
![Page 7: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/7.jpg)
04/11/23 21:51
History of discovery of immunity “Immune” meaning Noticing immunity centuries ago Small pox Edward Jenner Recent developments
![Page 8: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/8.jpg)
04/11/23 21:51
![Page 9: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/9.jpg)
04/11/23 21:51
1st Line defense: Physical and chemical barriers
Skin – acts as a barrier to invasion Sweat – has chemicals which can kill different
pathogens. Tears - have lysozyme which has powerful digestive
abilities that render antigens harmless. Saliva – also has lysozyme. Mucus - can trap pathogens, which are then sneezed,
coughed, washed away, or destroyed by chemicals. Stomach Acid – destroys pathogens
![Page 10: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/10.jpg)
04/11/23 21:51
Innate Adaptive
Immunity
Immunity
Cellular HumoralCellular Humoral
Let us see this video about immunity
![Page 11: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/11.jpg)
04/11/23 21:51
Inflammation
Inflammation is a nonspecific response of living tissue to localize and eliminate the injurious agent
Immune Response
![Page 12: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/12.jpg)
04/11/23 21:51
Inflammation The word inflammation means "setting on
fire" (16th century), and the process has been known since ancient Egyptian times (c. 2500 B.C)
The cardinal signs of redness, swelling, heat, and pain were described by Celsus (first-century A.D.), and loss of function was added by Galen (130-200 A.D)
![Page 13: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/13.jpg)
04/11/23 21:51
Acute phase changes characterized by pronounced behavioral,
physiologic, biochemical and nutritional changes
Acute phase reactants Acute phase proteins
![Page 14: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/14.jpg)
04/11/23 21:51
C-reactive protein named for its capacity to precipitate the
somatic C-polysaccharide of Streptococcus Pneumoniae.
Systemic marker of inflammation produced by hepatocytes, predominantly
under transcriptional control by the cytokine IL-6
![Page 15: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/15.jpg)
04/11/23 21:51
The Immune system The immune system
recognizes, attacks, destroys, and remembers each pathogen that enters the body.
It does this by making specialized cells and antibodies that render the pathogens harmless.
![Page 16: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/16.jpg)
04/11/23 21:51
![Page 17: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/17.jpg)
04/11/23 21:51
Questions? What Happens during an infection ?
How can immune cells distinguish foreign invaders from our own cells ?
How can we make 100,000,000 different antibodies with only 30,000 genes ?
![Page 18: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/18.jpg)
04/11/23 21:51
Cells of the immune system
T-cell development
![Page 19: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/19.jpg)
04/11/23 21:51
Cells of the immune system
![Page 20: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/20.jpg)
04/11/23 21:51
Polymorphonuclear cells1- Neutrophils
Stored in bone marrow Released in response to infection Have surface receptors for IgG,
IgA, complement Phagocytose and destroy bacteria Short lived Dead neutrophils make a part of
pus
![Page 21: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/21.jpg)
04/11/23 21:51
Polymorphonuclear cells2-Basophils and mast cells
Basophil circulate Mast cells are tissue bound Released in response to infection Have surface receptors for IgE, complement C3, C5 Produce histamine, prostaglandins, leukotrienes and
proteases Involved in immune response to parasites Involved in immediate hypersensitivity
![Page 22: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/22.jpg)
04/11/23 21:51
Polymorphonuclear cells3-Eosinophils
Allergy Have surface receptors for IgG, complement
C3, C5 Also binds to IgE but less than mast cells or
basophils Phagocytose antigen antibody complexes
![Page 23: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/23.jpg)
04/11/23 21:51
Macrophage In the tissues Long lived Initiate immune responses as they display antigens
from the pathogens to the lymphocytes.
![Page 24: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/24.jpg)
04/11/23 21:51
Phagocytosis
![Page 25: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/25.jpg)
04/11/23 21:51
Lymphocytes B and T cells mature then
circulate in the blood and lymph
B-cells mature in bone marrow
T-cells mature in thymus
![Page 26: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/26.jpg)
04/11/23 21:51
B-Lymphocytes The huge variety is caused
by genes coding for abs changing slightly during development.
The number of plasma cells goes down after a few weeks
Antibodies stay in the blood longer but eventually their numbers go down too.
![Page 27: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/27.jpg)
04/11/23 21:51
T-Lymphocytes CD3 in all types CD4 in helper
![Page 28: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/28.jpg)
04/11/23 21:51
![Page 29: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/29.jpg)
04/11/23 21:51
Natural killer cells Large granular lymphocytes Recognize and destroy cells bedaring viral or
tumor surface markers
![Page 30: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/30.jpg)
04/11/23 21:51
Complement Definition : series of heat-labile serum proteins
Site : serum and all tissue fluids except urine and CSF
Synthesis : in liver – appear in fetal circulation during 1st 13 W Function : Responsible for certain aspects of immune response and inflammatory response
Activation : antigen-antibody complex or endotoxin, capsule series of proteins activated sequentially
Inactivation: inhibitors in plasma (short lived)
![Page 31: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/31.jpg)
04/11/23 21:51
Complement system Plasma protein sequence cascade Triggered by
Classic pathway Alternative pathway Lectin binding
Complement
![Page 32: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/32.jpg)
04/11/2304/11/23 21:5121:51
Complement ActivationComplement ActivationClassical PathwayClassical Pathway CC11
CC4 4 CC22
CC3 3 Alternative pathwayAlternative pathway CC55
CC66
CC77
CC88
CC99
Membrane damageMembrane damage
![Page 33: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/33.jpg)
04/11/2304/11/23 21:5121:51
Classic And Alterenative pathwaysClassic And Alterenative pathways
Classic Pathway Alternative pathwayClassic Pathway Alternative pathway
* Specific acquired immunity * Non-specific innate immunity* Specific acquired immunity * Non-specific innate immunity
* Initiated by antibody * Bacterial endotoxin, capsule* Initiated by antibody * Bacterial endotoxin, capsule
* Interaction of all components * C1, C4, C2 are by-passed* Interaction of all components * C1, C4, C2 are by-passed
* Properdin system not involved * Properdin system is involved* Properdin system not involved * Properdin system is involved
![Page 34: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/34.jpg)
04/11/23 21:51
Complement and disease Complement difficiency Difficiency of classic pathway components C3 difficiency Terminal complement protein difficiencies Difficiency of regulatory proteins
Heriditary angioedema PNH Complement consumption as in SLE
![Page 35: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/35.jpg)
04/11/23 21:51
Functions of Complement Biologically active complement products
have 3 main functions Opsonisation …… C3b Chemotaxis and inflammation……C3a, C5a Cell lysis……….. C5,C6,C7,C8,C9
![Page 36: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/36.jpg)
04/11/23 21:51
Immunoglobulins
![Page 37: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/37.jpg)
04/11/23 21:51
![Page 38: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/38.jpg)
04/11/23 21:51
Immunoglobulins & age
![Page 39: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/39.jpg)
04/11/23 21:51
Plasma protein electrophoresis
![Page 40: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/40.jpg)
04/11/23 21:51
Antigens Antigens are macromolecules that elicit an immune
response in the body. The most common antigens are proteins and polysaccharides.
Hapten: incomplete Ag which can be conjugated with a carrier protein to form a complete Ag.
![Page 41: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/41.jpg)
04/11/23 21:51
Cytokines hormone-like soluble low molecular weight
protein molecules that act, generally in a paracrine fashion, to regulate immune responses
They are secreted not only by lymphocytes and macrophages but also by endothelial cells, adipocytes, neurons, glial cells, and other types of cells
![Page 42: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/42.jpg)
04/11/23 21:51
Chemokines cytokines that regulate cell movement and
trafficking; they attract neutrophils and other white blood cells to areas of inflammation or immune response.
![Page 43: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/43.jpg)
04/11/23 21:51
Interferons are potent cytokines that possess antiviral,
immunomodulating, and antiproliferative activities Interferon-α, Interferon-β & Interferon-γ Recombinant, natural, and pegylated IFNs currently
are available for treatment of condyloma acuminatum, chronic HCV infection, chronic
HBV infection, Kaposi's sarcoma in HIV-infected patients, other malignancies, multiple sclerosis
![Page 44: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/44.jpg)
04/11/23 21:51
Tolerance It is a specific immunologic unresponsiveness Unresponsiveness to self antigens is known as
auto tolerance
![Page 45: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/45.jpg)
04/11/23 21:51
ToleranceB-cells become tolerant to self by two mechanisms: 1) Clonal deletion Probably while B-cell precursors are in bon marrow
2) Clonal anergy B cells in the periphery
Tolerance in B-cells is less complete than in T-cells
The most autoimmune diseases are mediated by antibodies
![Page 46: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/46.jpg)
04/11/23 21:51
Factors affecting induction of tolerance Maturity of the immune system Antigen complexity Antigen dose Continuous presence of antigen Immunosuppressive drugs
![Page 47: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/47.jpg)
04/11/23 21:51
Clinical importance of tolerance Organ transplantation Tumor development Autoimmune diseases
![Page 48: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/48.jpg)
04/11/23 21:51
Autoimmune Diseases Autoimmune diseases occur due to breakdown of
the mechanisms that maintain auto tolerance
Auto-antibodies and self reactive T-cells are produced, resulting in tissue damage by several mechanisms
![Page 49: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/49.jpg)
04/11/23 21:51
References Lecture notes: Immunology 2010 Essential revision notes for MRCP 2009 Merck manual : online textbook Kumar & Klark : Clinical Medicine 2009 Other Web Resources & books
![Page 50: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/50.jpg)
04/11/23 21:51
![Page 51: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/51.jpg)
04/11/23 21:51
Understanding Immunology(2)
![Page 52: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/52.jpg)
04/11/23 21:51
Immunodeficiency
Immunopathology
Immunopathology
Autoimmunity
Hypersensitivity
LymphoproliferativeDiseases
![Page 53: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/53.jpg)
04/11/23 21:51
Immunodeficiency
![Page 54: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/54.jpg)
04/11/23 21:51
Acquired Immunodeficiency Infections Drugs and toxins Radiation Malignancy Malnutrition , Diabetes & Renal failure Splenectomy & Thymectomy Aging Stress
![Page 55: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/55.jpg)
04/11/23 21:51
HIV/AIDS Infects T-helper cells Progressive decline in CD4 counts Impaired cell mediated immunity Associated polyclonal activation of B-cells
and hypergamaglobulinemia
![Page 56: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/56.jpg)
04/11/23 21:51
Immune response to HIV
![Page 57: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/57.jpg)
04/11/23 21:51
CD4 depletion along the course of HIV
![Page 58: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/58.jpg)
04/11/23 21:51
Primary immunodeficiency Immune system not fully developed until at
least two years of age. Immuno-competent kids may have up to six
URIs per year. Ten URIs per year if they attend daycare.
Risk Factors for Frequent Infections When to suspect?
![Page 59: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/59.jpg)
04/11/23 21:51
Complementdeficiencies
Immunodeficiency
Immunodeficiency
B-cell disorders
Neutrophil Disorders
T-cell disorders
Combined B and T-cell disorders
![Page 60: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/60.jpg)
04/11/23 21:51
Neutrophil disorders Chronic granulomatous disease Chediak-Higashi disease Hyper Ig-E syndrome Myeloperoxidase deficiency Lazy Leukocyte Syndrome Leukocyte adhesion deficiency
![Page 61: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/61.jpg)
04/11/23 21:51
Lymphocyte disorders
![Page 62: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/62.jpg)
04/11/23 21:51
B-cell disorders IgA deficiency Common variable immunodeficiency Bruton’s X-linked agamaglobulinemia( no
circulating B-cells)
![Page 63: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/63.jpg)
04/11/23 21:51
T-cell disorders Digeorge syndrome Nezelof syndrome Purine nucleoside phosphorylase deficiency
![Page 64: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/64.jpg)
04/11/23 21:51
Combined B- and T-cell disorders Severe combined immunodeficiency Reticular dysgenesis Ataxia telangiectasia Wiskott-Aldrich syndrome
![Page 65: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/65.jpg)
04/11/23 21:51
Diagnosis of primary immunodeficiency History Examination Investigations of the immune system
![Page 66: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/66.jpg)
04/11/23 21:51
Clinical history
![Page 67: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/67.jpg)
04/11/23 21:51
Disease Specific Skin Findings Eczema and petechiae – Wiskott-Aldrich
Syndrome Telangiectasia – Ataxia-Telangiectasia Oculocutaneous albinism – Chediak-Higashi Dermatomyositis-like rash – XLA Chronic dermatitis – Hyper-IgE Generalized molluscum, extensive warts,
candidiasis – T-Cell defects
![Page 68: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/68.jpg)
04/11/23 21:51
2 -Autoimmunity
![Page 69: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/69.jpg)
04/11/23 21:51
![Page 70: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/70.jpg)
04/11/23 21:51
Type-1 diabetes
![Page 71: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/71.jpg)
04/11/23 21:51
Etiology of autoimmune diseases Genetic predisposition Cross reactivity Alteration of self antigens Hormonal influences
![Page 72: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/72.jpg)
04/11/23 21:51
Mechanisms Of Disease Production in autoimmunity
1) Binding of an autoantibody to host cells result in complement fixation and tissue destruction
e.g. Haemolytic anemia (Type II hypersensitivity)2) Formation of immune complexes and their deposition in tissues, joints, kidney and skin The immune complexes fix complement resulting in tissue damage e.g. SLE and rheumatoid arthritis (Type III hyper.) 3) DTH reactions (Type IV)) due to auto reactive T-cells e.g. Ulcerative colitis, multiple sclerosis and type I diabetes
![Page 73: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/73.jpg)
04/11/23 21:51
Auto-antibodies ANA Anti-dsDNA Anti-smith RF Anti-Ro Anti-La ANCA ASMA Anti-mitochondrial
![Page 74: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/74.jpg)
04/11/23 21:51
Transplacental transfer
![Page 75: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/75.jpg)
04/11/23 21:51
3 -Allergy and Hypersensitivity Immune responses with undesirable
consequences 5 Types Type I: Anaphylactic or immediate Type II:Antibody dependant cytotoxcicity Type III:Immune complex mediated or Arthus TypeIV: Cell mediated or delayed Type V: Stimulatory
![Page 76: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/76.jpg)
04/11/23 21:51
![Page 77: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/77.jpg)
04/11/23 21:51
4 -Malignancies of the immune system Lymphocytosis and lymphadenopathy Leukemias Lymphomas Mylomas and monoclonal gammopathies
![Page 78: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/78.jpg)
04/11/23 21:51
Hodgkin's disease
![Page 79: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/79.jpg)
04/11/23 21:51
Immunity and cancer Tumor immunology Tumor antigens Immune surveillance system Tumor escape from immune surveillance
![Page 80: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/80.jpg)
04/11/2304/11/23 21:5121:51
Tumor MarkersTumor Markers
* Tumor markers :* Tumor markers :
Tumor antigensTumor antigens
* They are either or* They are either or
Tumor products Tumor products
(enzymes and hormones)(enzymes and hormones)
* Tumor products are released in the serum of patients* Tumor products are released in the serum of patients
* They are used to * They are used to confirm diagnosisconfirm diagnosis and and follow upfollow up the the response to response to therapytherapy
![Page 81: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/81.jpg)
04/11/2304/11/23 21:5121:51
Tumor AntigensTumor Antigens
1) Alpha fetoprotein antigen (AFP)1) Alpha fetoprotein antigen (AFP) in cases of hepatoma in cases of hepatoma
2) Carcinoembryoinic antigen (CEA)2) Carcinoembryoinic antigen (CEA) in gastrointestinal in gastrointestinal tumors, tumors of biliary system and cancer breasttumors, tumors of biliary system and cancer breast
3) Cancer antigen 1253) Cancer antigen 125 (CA 125)(CA 125) in ovarian carcinoma in ovarian carcinoma
4) Cancer antigen 15-3 (CA15-3)4) Cancer antigen 15-3 (CA15-3) in breast cancer in breast cancer
5) Cancer antigen 19-95) Cancer antigen 19-9 in colon and pancreatic tumor in colon and pancreatic tumor
6) Prostatic specific antigen (PSA)6) Prostatic specific antigen (PSA) in prostatic tumors in prostatic tumors
![Page 82: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/82.jpg)
04/11/2304/11/23 21:5121:51
Tumor ProductsTumor Products
a) Hormones :a) Hormones :
-- Human chorionic gonadotrophins (HCG)Human chorionic gonadotrophins (HCG) are secreted are secreted
in cases of choriocarcinomain cases of choriocarcinoma
- Thyroxin (T3 & T4)- Thyroxin (T3 & T4) is secreted in cases of cancer is secreted in cases of cancer
of thyroid glandof thyroid gland
b) Enzymes :b) Enzymes :
- Acid phosphatase- Acid phosphatase enzymes in cases of cancer prostae enzymes in cases of cancer prostae
- Alkaline phosphatese, lipase and amylase- Alkaline phosphatese, lipase and amylase enzymes in enzymes in cases of cancer pancreascases of cancer pancreas
![Page 83: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/83.jpg)
04/11/23 21:51
References Lecture notes: Immunology 2010 Essential revision notes for MRCP 2009 Merck manual : online textbook Kumar & Klark : Clinical Medicine 2009 Other Web Resources & books
![Page 84: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/84.jpg)
04/11/23 21:51
![Page 85: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/85.jpg)
04/11/23 21:51
Understanding Immunology
(3)
![Page 86: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/86.jpg)
04/11/23 21:51
Immunization
Therapeutic applications of Immunology
Therapeutic applications of Immunology
Immunomodulation
Transplantation
Immunosupression
Anti-allergic
Replacement
![Page 87: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/87.jpg)
04/11/23 21:51
Immunization Passive immunization Active immunization
![Page 88: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/88.jpg)
04/11/23 21:51
History of immunization 1721---------Variolation 1796---------vaccination 1885--------- Rabies 1925--------- Toxoids 1954---------Salk 1956---------Sabin 1975--------- hepatitis B 1995--------- hepatitis A 2007---------- HPV
![Page 89: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/89.jpg)
04/11/23 21:51
Types of vaccines Killed vaccines
Salk , pertussis, typhoid, rabies
Live attenuated vaccines BCG, sabin, rubella, measles, mumps
Subunit vaccines Hepatitis B, H influenza, strept pneumonia
![Page 90: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/90.jpg)
04/11/23 21:51
No satisfactory vaccine for HIV, HCV Herpes viruses Rhinoviruses T.B Leprosy Cholera Parasites
![Page 91: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/91.jpg)
04/11/23 21:51
Pneumococcal vaccination INDICATIONS:
Primary vaccination (conjugate vaccine) children 2 yr. or older with
Anatomical or functional asplenia Sickle cell disease Nephrotic syndrome Immunosuppression
![Page 92: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/92.jpg)
04/11/23 21:51
Contraindications of vaccines Moderate or severe illness with or without fever Anaphylactic reaction to vaccine or vaccine
constituent Live attenuated vaccines
Pregnant women Immunocompromised / Immunosuppressed
children within 3-11 months of immunoglobulin
administration
![Page 93: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/93.jpg)
04/11/23 21:51
Invalid contraindications to vaccines Mild to moderate local reaction Mild acute illness with or without low grade fever Current antimicrobial therapy Convalescent phase of illnesses Prematurity and low birth weight History of penicillin or other nonspecific allergies Malnutrition
![Page 94: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/94.jpg)
04/11/23 21:51
Types of grafts Autografts Isografts Allografts (homograft): Xenograft (heterograft):
![Page 95: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/95.jpg)
04/11/23 21:51
Major Histocompatibility Complex (MHC)
The MHC is a closely linked complex of genes that govern production of the major histocompatibility
In humans, MHC resides on the short arm of chromosome 6
Three genes (HLA-A, HLA-B, HLA-C) code for the class I MHC proteins
Several HLA-D loci determine the class II MHC proteins i.e. DP, DQ and DR
HLA genes are very diverse (polymorphic)i.e. there are many alleles of the class I and II genes
![Page 96: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/96.jpg)
04/11/23 21:51
Class III MHC Between the class I and class II gene loci, there is a
third locus (Class III)
This locus contains genes encoding tumor necrosis factor, lymphotoxin and two complement components (C2 and C4)
Class III antigens do not participate in MHC restriction or graft rejection
![Page 97: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/97.jpg)
04/11/23 21:51
MHC I & II
MHC Class I MHC Class II
Nomenclature HLA-A, HLA-B, HLA-C HLA-DP, HLA-DQ ,
HLA-DR
Found on All nucleated somatic cells Macrophages, B-cells, Dentritic cells, langerhans
cells of skin and activated T cells
Recognized by CD8 TC cells CD4 TH cells
Functions Presentation of Ag to TC cells leading to elimination of tumor or infected host
cell
Presentation of Ag to TH cells which secrete
cytokines
![Page 98: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/98.jpg)
04/11/23 21:51
MHC and antigen presentation T-cells are only activated when they
recognize both antigen and class I MHC molecules in association
Helper T-cells recognize antigens on antigen-presenting cells only when the antigens are presented on the surface of cells in association with class II MHC
![Page 99: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/99.jpg)
04/11/23 21:51
Matching with donors HLA DR and HLA B in the kidney Heart and liver survive well with
immunosupression
![Page 100: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/100.jpg)
04/11/23 21:51
Types of rejection Hyperacute rejection Acute Rejection Acute late Chronic or late rejection
![Page 101: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/101.jpg)
04/11/23 21:51
Graft Versus Host reaction (GVH) An immunologically competent graft is transplanted
into an immunologically suppressed recipient (host)
The grafted cells survive and react against the host cells i.e instead of reaction of host against the graft, the reverse occurs
GVH reaction is characterized by fever, pancytopenia, weight loss, rash , diarrhea, hepatsplenomegaly and death
![Page 102: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/102.jpg)
04/11/23 21:51
Immunosupression Calcineurin inhibitors Azathioprin Methotrexate Cyclophosphamide
![Page 103: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/103.jpg)
04/11/23 21:51
Replacement therapy IV IG C1 estrase
![Page 104: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/104.jpg)
04/11/23 21:51
IG therapy IV SC Indications Side effects
![Page 105: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/105.jpg)
04/11/23 21:51
Antibodies as drugs Infliximab Etanercept Anakinra Rutiximab Abciximab Digibind Natalizumab
![Page 106: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/106.jpg)
04/11/23 21:51
Nomenclature of monoclonal absPrefix Target Source Suffix
variable
-o(s)- bone -u- human
-mab
-vi(r)- viral -o- mouse
-ba(c)- bacterial -a- rat
-li(m)- immune -e- hamster
-le(s)- infectious lesions -i- primate
-ci(r)- cardiovascular -xi- chimeric
-mu(l)- musculoskeletal -zu- humanized
-ki(n)- interleukin -axo- rat/murine hybrid
-co(l)- colonic tumor
-me(l)- melanoma
-ma(r)- mammary tumor
-go(t)- testicular tumor
-go(v)- ovarian tumor
-pr(o)- prostate tumor
-tu(m)- miscellaneous tumor
-neu(r)- nervous system
-tox(a)- toxin as target
![Page 107: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/107.jpg)
04/11/23 21:51
Rutiximab( anti CD-20) Rituxan® by Genentech Anti-B cell (CD20) antibody First approved in 1997 for use in B-cell lymphoma Given in combination with Methotrexate Directed for patients who do not respond to Anti-
TNF treatments Indicates the rheumatoid arthritis has a B cell
component to its pathology
![Page 108: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/108.jpg)
04/11/23 21:51
Desensitization In ttt of allergic conditions
![Page 109: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/109.jpg)
04/11/23 21:51
Anti-allergic drugs Antihistamines Mast cell stabilizers others
![Page 110: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/110.jpg)
04/11/23 21:51
Immunotherapy for cancer Pathogen vaccines Tumor vaccines others
![Page 111: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/111.jpg)
04/11/23 21:51
References Lecture notes: Immunology 2010 Essential revision notes for MRCP 2009 Merck manual : online textbook Kumar & Klark : Clinical Medicine 2009 Other Web Resources & books
![Page 112: Immunology 1, 2, 3](https://reader037.vdocument.in/reader037/viewer/2022102805/554b0b62b4c9056f098b461e/html5/thumbnails/112.jpg)
04/11/23 21:51